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Abstract  
Neauvia Intense is biocompatible, injectable hyaluronic acid (HA) filler PEG cross-linked for facial soft-tissue 
augmentation that provides volume to tissues. The aim of the present study is to evaluate the sensitivity of 
Neauvia Intense in hyaluronidase from bovine testes in a time-course analysis. The test is based on the 
colourimetric determination of the N-acetyl – D - glucosamine (NAG) released by the hyaluronidase in 
standardised conditions. The in vitro conditions involve the treatment of Neauvia Intense with a known 
concentration of the enzyme (6080U/ml). The NAG content was determined at different times to assess the 
kinetics of the degradation (1h, 3h, 6h, 24h, 48h, 72h, 120h, and 168h); the Ehrlich’s reagent was used for the 
colourimetric quantification, by the method described by Reissing and colleagues. The intensity of the violet colour 
developed after the chemical reaction was proportional to the NAG present in each sample. A microplate reader 
at 585 nm read the absorbance. The amount of NAG released by the product was proportional to the time of 
incubation with bovine hyaluronidase, reaching a plateau after 168 hours. 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Hyaluronic acid (HA) is a high-molecular-
mass linear anionic polysaccharide without branching 
side - chains, composed of 2000 - 25000 disaccharide 
units formed by glucuronic acid and N – acetyl – D -
glucosamine (NAG), which are linked by β(1,4)-
glycosidic bond, reaching 105 – 107 Da in molecular 
mass [1][2][3][4][5]. HA is a major component of the 
extracellular matrix in the human body, as it is present 
in the skin, synovial fluid, loose connective tissues, 
umbilical cord, vitreous body of the eye and cartilage 
[6] Several biological functions are fulfilled by this 
molecule, as it plays a major role in the organization 
and integrity of the extracellular matrix, thereby 
participating in the preservation of the form and the 
spatial arrangement of tissue components. It is also 
involved in numerous biological and physiological 
functions, such as cell motility, cell-matrix adhesion, 
and cell proliferation, water homeostasis of tissues or 
joint lubrication [7]. Thanks to the HA molecule’s 
capability to absorb a large volume of water, it can 
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hydrate tissues and finally to maintain the moisture of 
the skin [8][9].  
The degradation of the HA molecule occurs in 
the body by three mechanisms: the attack by free 
radicals, enzymatic processes (hyaluronidases) or 
thermally [10]. The hyaluronidases are 
endoglycosidases that cleave HA, reducing its 
viscosity [11]. Hyaluronidases could be classified into 
three groups according to their mechanism of action 
and end products: mammalian hyaluronidase (testis 
tube), leech/hookworm hyaluronidase and microbial 
hyaluronidase [12][13]. Mammalian and microbial 
hyaluronidases act on the β -1, 4 - glycosidic linkages 
of HA, while the leech/hookworm hyaluronidase 
degrades the β - 1, 3 - glycosidic bond; all of them 
degrade the HA molecule and produce 
oligosaccharides of different chain length [14][15]. 
These enzymes are normally employed for several 
purposes, such as the prevention of tissue damage 
after the extravasation of different substances, for 
oedema reduction [16] and to prevent the diffusion of 
several substances injected subcutaneously 
[17][18][19][21]. 
In the last decade, HA has been considered, 
in aesthetic medicine, as an ideal substance to be 
used to augment the skin volume, being highly 
biocompatible, non-immunogenic and capable of 
binding water to a large extent [22]. In order to 
increase the biomechanical properties and the 
resistance to enzymatic break down of natural HA 
containing preparations, various methods have been 
developed for chemical modification or cross-linking of 
native HA into gels by covalent links, resulting in 
larger and most stable derivatives that retain HA 
biocompatibility and biodegradability in vivo [23][24].  
In the HA hydrogel evaluated the crosslinking 
reaction occurring with cross-linking agents based on 
epoxides, in a strongly basic environment with the 
formation of ether bonds C – O - C, which is among 
the most solid and consequently the most resistant to 
degradation. 
The reaction consists in the epoxide ring 
opening, in the simultaneous deprotonation of the 
hydroxyl group (in a basic environment is more 
nucleophilic than the carboxylic deprotonated group) 
and in the formation of the bond C – O - C.  
The crosslinker used for this type pf reaction 
to create Neauvia Hydrogel was PEGDE (Figure 1).  
In aesthetic medicine, hyaluronidases are used for 
dissolving the injected hyaluronic acid filler, 
eliminating nodules, correcting the injection of 
excessive quantities of injected filler, or avoiding 
ischemic complications derived from this practice 
[25][26]. The literature reported a wide range of 
techniques to analyse the in vitro degradation rate of 
crosslinked HA hydrogels by the hyaluronidase 
enzyme [27][28]: change in viscosity, in water content, 
gel plate assay in Petri dishes or colourimetric assays 
for the released glucuronic acid. 
 
Figure 1: Hyaluronic acid (HA) crosslinking with poly(ethylene 
glycol) diglycidyl ether (PEGDE) 
 
The aim of the present work is to evaluate the 
sensitivity to a bovine hyaluronidase enzyme of 
Neauvia Intense®(MatexLab SA, Lugano, CH), a 
product composed of pure hyaluronic acid of probiotic 
origin (Bacillus Subtilis) PEG cross-linked 
(polyethylene glycol) [29][30][31].  
 
 
Materials and Methods 
 
Chemicals and instruments 
The sensitivity of Neauvia Intense®(MatexLab 
SA, Lugano, CH) to hyaluronidase was tested. This 
product is composed of pure hyaluronic acid of 
probiotic origin (Bacillus Subtilis) PEG cross-linked 
(polyethylene glycol) to obtain a 3D hydrogel matrix, 
that could be considered a completely biocompatible 
and degradable hydrogel, with volumizing effect, 
typical of the HA filler cross-linked polymer 
Type I - S hyaluronidase from bovine testis 
was purchased from Sigma Aldrich (ref. H3506, 
451Units/mg); all other chemicals were of the highest 
purity available. 
The absorbance was measured using a 
Multiskan - Go (Fisher Scientific) spectrophotometer. 
 
Sample preparation 
Neauvia Intense® was weighed (0.2g) and 
placed in the bottom of glass tubes. The tubes were 
then centrifuged for 5min at 1000g in a refrigerated 
bench centrifuge (Megastar 600R, VWR) equipped 
with a swinging bucket rotor. At the end of the 
centrifugation, thin pellets firmly attached at the 
bottom of the tubes were obtained. 
 
 
Hyaluronidase sensitivity test 
To measure the degradation rate of the 
hyaluronidase on hydrogels, a Type I - S 
hyaluronidase from bovine testes (Sigma Aldrich; ref. 
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H3506, 451 Units/mg) was prepared at the 
concentration of 6080U/ml in an isotonic phosphate-
NaCl buffer at a pH of 7.4 [2]. The glass tubes 
containing the gel pellets and the hyaluronidase 
solution were pre-incubated separately for 10min at 
37°C. Then, 100 µl of the enzyme solution was added 
gently onto the surface of the gels and, after the 
incubation for 1h, 3h, 6h, 24h, 48h, 72h, 120h and 
168h the enzymatic reaction was stopped by the 
addition of 0.1ml of a potassium tetraborate solution 
(0.8 mol/L, pH 9.1), followed by a stirring with a vortex 
mixer and heating for 3min at 100°C. The tubes were 
then cooled at room temperature, and the released 
NAG was assayed. 
 
Assay of the released NAG 
The measurement of the released NAG was 
performed according to the Reissig et al. method [1]. 
Briefly, a diluted 1:10 Ehrlich’s reagent (Sigma 
Aldrich) in acetic acid was added to the tubes. The 
samples were vortexed and incubated for 20min at 
37°C, to develop a violet colour, proportional to the 
released NAG content in each sample. The tubes 
were centrifuged at 1000 g for 15min to remove the 
gel fragments and the turbidity in the reaction. Then, 
the samples were read with a microplate reader 
(Multiskan-Go, Fisher Scientific) at 585 nm 
wavelength against the blank prepared with the only 
phosphate buffer and the Ehrlich’s reagent. 
 
 
Results 
 
Hyaluronidase sensitivity test 
To measure the degradation rate of Neauvia 
Intense, the product was weighed and incubated with 
a constant concentration of hyaluronidase enzyme. 
The amount of NaHA (mg) contained in the weighed 
product was reported in Table 1. 
Table 1: Amount of NaHa (mg) contained in each sample. The 
indicated values correspond to the mean of at least two 
measurements ± SD for each time of analysis 
 
 
The results of the time - course degradation of 
crosslinked HA by hyaluronidase are reported in Table 
2. 
Table 2: Absorbance values obtained after incubation of the 
samples with hyaluronidase and the relative amount of NAG 
(mg) released. The indicated values correspond to the mean of 
at least two measurements ± SD for each time of analysis 
 
Results obtained after different times of 
incubation of Neauvia Intense® with a constant 
amount of hyaluronidase enzyme (Figure 2) showed 
an increase in the absorbance values (585 nm) 
concerning the blank sample.  
 
Figure 2: Absorbance values obtained after the incubation of 
Neauvia Intense® with the hyaluronidase enzyme for different times 
of treatment. Gel wt= 0.2g; Vol hyaluronidase = 100µl; Conc. 
hyaluronidase sample= 6080 U/ml;Temp= 37°C. Each point is the 
mean of at least two measurements ± SD 
 
Interpolating these data with a standard NAG 
curve (data not shown), the amount of NAG (µg) 
released per g of product was calculated (Figure 3). 
 
Figure 3: NAG amount (mg/g) released after different times of 
incubation of Neauvia Intense® with the hyaluronidase enzyme. Gel 
wt= 0.2g; Vol hyaluronidase = 100µl; Conc. hyaluronidase sample= 
6080 U/ml;Temp= 37°C. Each point is the mean of at least two 
measurements ± SD 
Zerbinati et al. Sensitivity of a Hyaluronic Acid PEG Cross - Linked to Bovine Testes Hyaluronidase 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci. 2018 Jan 25; 6(1):20-24.                                                                                                                                                               23 
 
It is possible to note that the amount of NAG 
released increased with time and eventually levelled 
off from 120h of incubation on, suggesting complete 
digestion of the initial NaHA content in the sample. 
In this study, the sensitivity of the product 
Neauvia Intense to a hyaluronidase from bovine 
testes was assayed. The growing interest of the 
aesthetic medicine sector in the use of such enzymes 
to dissolve or correct the injected hyaluronic acid filler, 
also avoiding misplacement HA complications derived 
from this injection practice, has been the starting point 
to deepen the mechanisms of action of the 
hyaluronidase on the Neauvia Intense product. 
In detail, the method has been set up defining 
a determined quantity of product that was incubated 
with a constant concentration of hyaluronidase (6080 
U/ml) at 37°C for a period ranging from 1 h to 168 h. 
The amount of NAG released, evaluated by the use of 
the Ehrlich’s reagent, was calculated from the 
absorbance values measured at determined times of 
analysis and was considered as the factor 
corresponding to the degradation rate of the hydrogel 
caused by the enzymatic digestion process. The 
calculation was based on the interpolation of the 
absorbance values obtained from each sample with 
the values obtained for the standard NAG curve in µg. 
To this end, the centrifugation step of the final medium 
reaction before the absorbance measurement was 
necessary to remove the turbidity and small gel 
fragments still present in the tube [32]. 
The obtained results showed that the product 
Neauvia Intense, put in contact with a constant 
concentration of hyaluronidase enzyme, released a 
NAG quantity directly proportional to the incubation 
time and reached a plateau (maximum observed 
absorbance value) after 120h, monitored until 168h of 
contact with the enzyme. This has been considered 
the evidence that the hyaluronidase enzyme reached 
the highest levels of NAG release and consequently 
the maximum level of degradation of the HA molecule 
contained in the hydrogel. 
The obtained results demonstrated that the 
Neauvia Intense product is sensitive to the bovine 
testes hyaluronidase, by a time course analysis that 
examined the rate of degradation of the HA molecule 
present in the hydrogel. Moreover, it is possible to 
conclude that the hyaluronidase brought to a complete 
degradation of the amount of Neauvia Intense 
product, in the experimental conditions performed, 
after 120h of treatment with the enzyme in an in vitro 
assay. 
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